Literature DB >> 19156133

Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects.

Chan Il Chang1, Jae Wook Yoo, Sun Woo Hong, Shi Eun Lee, Hye Suk Kang, Xiangao Sun, Harry A Rogoff, Changill Ban, Soyoun Kim, Chiang J Li, Dong-Ki Lee.   

Abstract

Small interfering RNAs (siRNAs) are short, double-stranded RNAs that mediate efficient gene silencing in a sequence-specific manner by utilizing the endogenous RNA interference (RNAi) pathway. The current standard synthetic siRNA structure harbors a 19-base-pair duplex region with 3' overhangs of 2 nucleotides (the so-called 19+2 form). However, the synthetic 19+2 siRNA structure exhibits several sequence-independent, nonspecific effects, which has posed challenges to the development of RNAi therapeutics and specific silencing of genes in research. In this study, we report on the identification of truncated siRNA backbone structures with duplex regions shorter than 19 bp (referred to as asymmetric shorter-duplex siRNAs or asiRNAs) that can efficiently trigger gene silencing in human cell lines. Importantly, this asiRNA structure significantly reduces nonspecific effects triggered by conventional 19+2 siRNA scaffold, such as sense-strand-mediated off-target gene silencing and saturation of the cellular RNAi machinery. Our results suggest that this asiRNA structure is an important alternative to conventional siRNAs for both functional genomics studies and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156133      PMCID: PMC2835116          DOI: 10.1038/mt.2008.298

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  38 in total

1.  Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

3.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 4.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

5.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

6.  Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs).

Authors:  Stephan P Persengiev; Xiaochun Zhu; Michael R Green
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

7.  Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells.

Authors:  Xiaoying Zhou; Frank R Murphy; Nitu Gehdu; Junlong Zhang; John P Iredale; R Christopher Benyon
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

8.  Potent RNAi by short RNA triggers.

Authors:  Chia-Ying Chu; Tariq M Rana
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

9.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

10.  Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

Authors:  Javier Martinez; Agnieszka Patkaniowska; Henning Urlaub; Reinhard Lührmann; Thomas Tuschl
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

View more
  37 in total

1.  Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo.

Authors:  Donald J Foster; Scott Barros; Rick Duncan; Sarfraz Shaikh; William Cantley; Amy Dell; Elena Bulgakova; Jonathan O'Shea; Nate Taneja; Satya Kuchimanchi; Christopher B Sherrill; Akin Akinc; Gregory Hinkle; Amy C Seila White; Bo Pang; Klaus Charisse; Rachel Meyers; Muthiah Manoharan; Sayda M Elbashir
Journal:  RNA       Date:  2012-01-31       Impact factor: 4.942

Review 2.  RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics.

Authors:  Nicholas M Snead; John J Rossi
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 3.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

4.  Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.

Authors:  Pooja Dua; Jae Wook Yoo; Soyoun Kim; Dong-ki Lee
Journal:  Mol Ther       Date:  2011-06-14       Impact factor: 11.454

Review 5.  Structural diversity repertoire of gene silencing small interfering RNAs.

Authors:  Chan Il Chang; Helena Andrade Kim; Pooja Dua; Soyoun Kim; Chiang J Li; Dong-ki Lee
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

6.  RNAi joins the "Singles Club".

Authors:  Veronica J Peschansky; Zicai Liang; Claes Wahlestedt
Journal:  Mol Ther       Date:  2012-11       Impact factor: 11.454

7.  Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3.

Authors:  Mark E Kleinman; Hiroki Kaneko; Won Gil Cho; Sami Dridi; Benjamin J Fowler; Alexander D Blandford; Romulo J C Albuquerque; Yoshio Hirano; Hiroko Terasaki; Mineo Kondo; Takashi Fujita; Balamurali K Ambati; Valeria Tarallo; Bradley D Gelfand; Sasha Bogdanovich; Judit Z Baffi; Jayakrishna Ambati
Journal:  Mol Ther       Date:  2011-10-11       Impact factor: 11.454

Review 8.  Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.

Authors:  Manjunath N Swamy; Haoquan Wu; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2016-03-21       Impact factor: 15.470

9.  The application of RNAi-based treatments for inflammatory bowel disease.

Authors:  Morten Tobias Jarlstad Olesen; Borja Ballarín-González; Kenneth Alan Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

10.  Versatile assays for high throughput screening for activators or inhibitors of intracellular proteases and their cellular regulators.

Authors:  Hideki Hayashi; Michael Cuddy; Vincent Chih-Wen Shu; Kenneth W Yip; Charitha Madiraju; Paul Diaz; Toshifumi Matsuyama; Muneshige Kaibara; Kohtaro Taniyama; Stefan Vasile; Eduard Sergienko; John C Reed
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.